Olivier Freytag
CEO & Founder
Olivier is a seasoned professional in drug development with a track record spanning over 15 years. His expertise covers the entire spectrum of the process, from discovery and preclinical development to the clinical development of Biotherapeutics. Olivier’s experience is not confined to a specific business size; he has made his mark in large pharmaceutical companies, mid-sized Pharma businesses, and agile biotech startups alike.
His scientific background, coupled with his skills in program and portfolio management and strategic operations, have been instrumental in the research and development of various biotherapeutics that are now in the clinical development phase.
Olivier is skilled in various areas of biotherapeutics, including monoclonal antibodies, bispecific antibodies, and recombinant proteins. His wide-ranging knowledge and strong leadership skills make him a key part of our consulting company and a great resource for our clients.
The only way to do great work is to love what you do
Steve Jobs